D16G (p.Asp16Gly) variant of IRS2 (Insulin receptor substrate 2)
D16G (p.Asp16Gly) in IRS2 (Insulin receptor substrate 2) is a missense change. The available variant effect predictions contribute to a CATVariant prioritization score of 0.22 / 1. The record also includes population frequency data and structural context.
D16G (p.Asp16Gly) variant details
- p.Asp16Gly
- Ensembl rs2138939885
- Missense
- Variant Prioritization Score for Impact Estimate 0.217
- REVEL 0.06
- CADD 17.30
- PolyPhen-2 0.00
- SIFT 0.16
- Population evidence available
- Structural context available